Mfn2 ubiquitination by PINK1/parkin gates the p97-dependent release of ER from mitochondria to drive mitophagy

  1. Gian-Luca McLelland
  2. Thomas Goiran
  3. Wei Yi
  4. Geneviève Dorval
  5. Carol X Chen
  6. Nadine D Lauinger
  7. Andrea I Krahn
  8. Sepideh Valimehr
  9. Aleksandar Rakovic
  10. Isabelle Rouiller
  11. Thomas M Durcan
  12. Jean-François Trempe
  13. Edward A Fon  Is a corresponding author
  1. Montreal Neurological Institute, McGill University, Canada
  2. McGill University, Canada
  3. Institute of Neurogenetics, University of Lübeck, Germany
9 figures, 1 table and 2 additional files

Figures

Figure 1 with 1 supplement
Ultrastructural analysis of ER-mitochondria contact during mitophagy in U2OS cells and dopaminergic neurons.

(A) Representative TEM images of mitochondria (‘M’) in contact with ER (pseudocoloured blue) in untreated and CCCP-treated U2OS:GFP-parkin cells. Scale bars, 500 nm. (B–E) Quantification of TEM from …

https://doi.org/10.7554/eLife.32866.002
Figure 1—figure supplement 1
Mitophagy reduces ER-OMM contacts of all intermembrane distances.

(A) Representative TEM image of an untreated U2OS:GFP-parkin WT cell highlighting ER-OMM distances of less than 100, 50 and 25 nm. Intermembrane distances (d) are indicated. Scale bars, 500 and 100 …

https://doi.org/10.7554/eLife.32866.003
Figure 2 with 1 supplement
Mfn2 is rapidly phosphoubiquitinated upon induction of mitophagy.

(A) Immunoblot analysis of protein turnover in glucose-maintained U2OS:GFP-parkin WT and A320R cells treated with 20 μM CCCP for the indicated time. (B) Higher exposures of Mfn2 and TOM20 …

https://doi.org/10.7554/eLife.32866.005
Figure 2—figure supplement 1
LC/MS of immunoprecipitated Mfn2.

(A) Base peak chromatograms indicating equal loading of both DMSO- and CCCP-treated samples from Figure 2F and G. (B) Extracted ion chromatograms of the indicated Ub and Mfn2 peptides from both …

https://doi.org/10.7554/eLife.32866.006
Figure 3 with 5 supplements
Mfn2 antagonizes mitophagy.

(A) Immunoblot analysis of whole-cell lysates from cells cultured in glucose or galactose transfected with control siRNA or siRNA targeting Mfn1 (‘siMfn1’) or Mfn2 (‘siMfn2’). (B) Mitochondrial …

https://doi.org/10.7554/eLife.32866.007
Figure 3—figure supplement 1
Mfn2 is a mitochondrion-ER tether.

(A) Representative TEM images of U2OS:GFP-parkin cells transfected with the indicated siRNA. ER tubules are pseudocoloured blue. Scale bar, 500 nm. (B–D) Quantification of mitochondrial length (B), …

https://doi.org/10.7554/eLife.32866.008
Figure 3—figure supplement 2
Mitochondrial respiration impedes mitophagy.

(A) Representative confocal images of U2OS:GFP-parkin (green) cells, grown on either glucose or galactose, treated with 20 μM CCCP for the indicated times. Cells were then fixed and stained for …

https://doi.org/10.7554/eLife.32866.009
Figure 3—figure supplement 3
Parkin recruitment kinetics in cells lacking both Mfns and other mitochondria-ER tethering factors.

(A) Immunoblot analysis of whole-cell lysates from cells cultured in glucose or galactose transfected with control siRNA or siRNA targeting Mfn1 (‘siMfn1’), Mfn2 (‘siMfn2’) or both mitofusins …

https://doi.org/10.7554/eLife.32866.010
Figure 3—figure supplement 4
Analysis of mitophagy in Mfn2 KO U2OS cells.

(A) Genomic sequence of human Mfn2 (exon 3) that was mutated in U2OS cells using CRISPR/Cas9. The arrow indicates the codon corresponding to methionine-1; leucine-29 (‘L29’), lysine-30 (‘K30’) and …

https://doi.org/10.7554/eLife.32866.011
Figure 3—figure supplement 5
Parkin recruitment in Mfn2-depleted cells requires PINK1 and phosphoubiquitin binding.

(A) Immunoblot analysis of PINK1 depletion in WT and Mfn2 KO (clone A4) U2OS cells treated with 20 μM CCCP for four hours. The arrowhead indicates the PINK1 band, while the asterisk indicates a …

https://doi.org/10.7554/eLife.32866.012
Figure 4 with 1 supplement
Parkin ubiquitinates Mfn2 in the HR1 domain to derepress mitophagy.

(A) Mfn2 KO:YFP-parkin WT cells were transfected with the indicated plasmid and CFP in a 3:1 ratio, then fixed and immunostained for TOM20 (red) and counterstained with Hoechst 33342 (blue). Scale …

https://doi.org/10.7554/eLife.32866.014
Figure 4—figure supplement 1
Location and conservation of ubiquitination and phosphorylation sites in Mfn2.

(A) Sequence alignment of sites of Mfn2 modification across species. Ubiquitinated lysines and phosphorylated serines and threonines are indicated by arrowheads. Residue numbering is according to …

https://doi.org/10.7554/eLife.32866.015
p97 governs ER-OMM contact via the extraction of Mfn2 complexes.

(A) Immunoblot analysis of NP-40-solubilized mitochondria, isolated from U2OS:GFP-parkin WT cells treated with 20 μM CCCP for the indicated time, separated by blue native- (BN-) and SDS-PAGE. (B, C) …

https://doi.org/10.7554/eLife.32866.017
Figure 6 with 1 supplement
Degradation of ubiquitinated Mfn2 involves p97 recruitment and activity.

(A) Representative confocal images of p97 recruitment to mitochondria in cells treated with 20 μM CCCP and/or 25 μM NMS-873 for the indicated time. Blue asterisks denote cells with mitochondrial …

https://doi.org/10.7554/eLife.32866.019
Figure 6—figure supplement 1
Analysis of pUb interactors from mouse brain.

(A) Workflow of protein purification, phosphorylation, pull-down and LC/MS. GST-4xUb G76V, which cannot be cleaved by the cellular Ub processing machinery, was phosphorylated on S65 by Tribolium …

https://doi.org/10.7554/eLife.32866.020
p97 and Mfn2 effect mitophagy through parkin substrate availability.

(A) U2OS:mtKeima cells were transfected with the indicated siRNA and GFP-parkin WT, and were treated with 20 μM CCCP (or DMSO) for five hours in the presence (dark grey box) or absence (light grey …

https://doi.org/10.7554/eLife.32866.022
Figure 8 with 1 supplement
In organello ubiquitination of Mfn2 and VDAC1.

(A) Workflow for the in organello ubiquitination assay, where HeLa cells are depolarized with 20 μM CCCP for four hours and mitochondria are isolated (‘mitoCCCP’, with control ‘mitoDMSO’). These are …

https://doi.org/10.7554/eLife.32866.024
Figure 8—figure supplement 1
Effect of NMS-873 on cytosol-free ubiquitination.

In organello ubiquitination reactions were performed in the presence or absence of 25 μM NMS-873. Reactions were incubated on ice for 30 min prior to a 60 min 37°C incubation. In the immunoblot …

https://doi.org/10.7554/eLife.32866.025
Dismantling of Mfn2 interorganellar bridges by PINK1, parkin and p97 during mitophagy.

(A) PINK1-phosphorylated Ub on Mfn2 initially recruits parkin to Mfn2 complexes, where it is phosphorylated and activated by PINK1. (B) Parkin and PINK1 cooperate to catalyze a pUb burst on Mfn2. (C)…

https://doi.org/10.7554/eLife.32866.027

Tables

Key resources table
Reagent type (species)
or resource
DesignationSource or referenceIdentifiersAdditional information
cell line (Homo sapiens)U2OSPMID 24446486
cell line (Hs)U2OS:GFPPMID 24446486
cell line (Hs)U2OS:GFP-parkin WTPMID 24446486
cell line (Hs)U2OS:GFP-parkin A320RPMID 28276439
cell line (Hs)Mfn2 KOthis papersee Plasmids and transfection
cell line (Hs)Mfn2 KO:YFP-parkin WTthis papersee Plasmids and transfection
cell line (Hs)Mfn2 KO:YFP-parkin C431Sthis papersee Plasmids and transfection
cell line (Hs)HeLaPMID 24446486
cell line (Hs)control-1NIHNCRM-1
cell line (Hs)control-2PMID 27641647
cell line (Hs)PRKN(del)PMID 20885945
transfected construct (Hs)HA-UbPMID 25216678
transfected construct (Hs)DsRed2-LC3PMID 18596167
transfected construct (Hs)Mfn1-HAPMID 15878861
transfected construct (Hs)Mfn2 WTPMID 15878861
transfected construct (Hs)Mfn2 K406Rthis papersee Plasmids and transfection
transfected construct (Hs)Mfn2 K416Rthis papersee Plasmids and transfection
transfected construct (Hs)Mfn2 K420Rthis papersee Plasmids and transfection
transfected construct (Hs)Mfn2 HR1this papersee Plasmids and transfection
transfected construct (Hs)Mfn2 HR2this papersee Plasmids and transfection
transfected construct (Hs)Mfn2 TS/AAthis papersee Plasmids and transfection
transfected construct (Hs)GFP-parkin WTPMID 24446486
biological sample (Mus musculus)parkin WT brain cytosolthis papersee In organello ubiquitination assays
biological sample (Mm)parkin KO brain cytosolthis papersee In organello ubiquitination assays
antibodyanti-actinMilliporeMAB1501
antibodyanti-B-III-tubulinSigmaT8660
antibodyanti-MAVSEnzoALX-210–929 C100
antibodyanti-cytochrome cBD556432
antibodyanti-GFPAbcamab6673IP
antibodyanti-GFPInvitrogenA6455WB
antibodyanti-Grp78Santa Cruzsc-376768
antibodyanti-HAAbcamab9134
antibodyanti-HK1Cell Signaling2024S
antibodyanti-Mfn1Santa Cruzsc-50330
antibodyanti-Mfn2SigmaM6319WB in Figure 3—figure supplement 2D
antibodyanti-Mfn2Cell Signaling9482all other assays (IF, WB, IP)
antibodyanti-CIV-COXIAbcamab14705
antibodyanti-p62ProgenGP62-C
antibodyanti-PDH E1aAbcamab110330
antibodyanti-PDH E2/E3bpAbcamab110333
antibodyanti-PDIAbcamab2792
antibodyanti-PINK1Cell Signaling6946
antibodyanti-pS65 UbMilliporeABS1513-I
antibodyanti-Rab11ACell Signaling2413
antibodyanti-Miro1SigmaHPA010687
antibodyanti-CII-SDHAAbcamab14715
antibodyanti-Stx17ProteinTech17815–1-AP
antibodyanti-THPel-FreezP40101-150
antibodyanti-TIM23BD611222
antibodyanti-TOM20Santa Cruzsc-11414
antibodyanti-TOM70Santa Cruzsc-390545
antibodyanti-Ub [FK2]EnzoBML-PW8810IF
antibodyanti-Ub [P4D1]Santa Cruzsc-8017WB
antibodyanti-CIII-core2Abcamab14745
antibodyanti-CIII-RieskeAbcamab14746
antibodyanti-p97Abcamab11433
antibodyanti-VDAC1Abcamab14734
recombinant protein (Rattus norvegicus)GST-R0RBR WTPMID 23661642
recombinant protein (Rn)GST-R0RBR A320Rthis papersee Plasmids and transfection
recombinant protein (Rn)GST-parkin WTPMID 28276439
recombinant protein (Rn)GST-parkin C431APMID 28276439
recombinant protein (Hs)UbcH7PMID 28276439
recombinant protein (Hs)UBE1BostonBiochemE-305
recombinant protein (Hs)UbiquitinBostonBiochemU-100H
recombinant protein (Hs)Usp2 catalytic domainBostonBiochemE-504
recombinant protein (Tribolium castaneum)TcPINK1PMID 24784582
recombinant protein (Hs)GST-4xUb G76VPMID 23670163
recombinant protein (Mm)His-p97PMID 19506019
commercial assay or kitQuikChange II site-directed mutagenesis kitAgilent200523
commercial assay or kitBCA protein assayThermoFisher23227
chemical compound, drugCCCPSigmaC2759
chemical compound, drugMG132SigmaM8699
chemical compound, drugHoechst 33342ThermoFisherH3570
chemical compound, drugNMS-873ApexBioB2168
software, algorithmBioToolsBruker
software, algorithmMASCOTMatrix Science
software, algorithmData AnalysisBruker
software, algorithmImagJNIH
software, algorithmPyMOLSchrodinger
software, algorithmExcelMicrosoft
software, algorithmPrismGraphPad

Additional files

Supplementary file 1

MS identification of selective Ub and pUb interactors.

Table depicting GST-4xUb interactors that are selective for S65-phosphorylated (top) or unphosphorylated (bottom) Ub. p97-related data (shaded in yellow) are also depicted in Figure 6—figure supplement 1C.

https://doi.org/10.7554/eLife.32866.028
Transparent reporting form
https://doi.org/10.7554/eLife.32866.029

Download links